We use cookies to improve your experience on VidNexa. We use necessary cookies to keep you signed in and keep the site secure, and — only with your permission — preference cookies (seen videos, recent categories), analytics cookies (a first-party visitor id and A/B assignment, first-party measurement, and Google Analytics), and marketing cookies (only when a third-party ad tag or slot is enabled).
Learn more about our privacy policy
Choose which non-essential cookies VidNexa may use. Necessary cookies are always on: they keep you signed in, protect forms, and keep the site secure.
Global Privacy Control: your browser is sending a GPC signal, so Analytics and Marketing stay off while it is on — even if you previously accepted them.
NecessarySession, feed security nonce, admin sign-in persistence. Always on.
PreferencesSeen-video list, recent categories, row preferences. Remember what you watched and browsed.
AnalyticsGoogle Analytics (GA4), run by Google, to measure traffic — it loads only if you allow this category — plus a first-party visitor id, A/B assignment and first-party viewing measurement used to test feed changes. Turning this off also deletes Google Analytics cookies already set.
MarketingThird-party ad tags and slots, only when an admin enables them. No marketing cookie is set by default.
Get the VidNexa apps
VidNexa on every screen — free for Android, Windows & Mac.
Doctors are warning patients using GLP-1 drugs like Ozempic and peptides of “serious consequences” if they fail to disclose their use before surgery. It comes a…
Doctors are warning patients using GLP-1 drugs like Ozempic and peptides of “serious consequences” if they fail to disclose their use before surgery.
It comes after a new study found there was an 11-fold risk of aspiration or regurgitation under general anaesthetic for GLP-1 users.
Subscribe: http://ab.co/1svxLVE
Read more here: https://www.abc.net.au/news/2026-10-07/peptides-ozempic-surgery-warning/107233212
Note: In most cases, our captions are auto-generated.
Doctors are warning patients using GLP-1 drugs like Ozempic and peptides of “serious consequences” if they fail to disclose their use before surgery.
It comes after a new study found there was an 11-fold risk of aspiration or regurgitation under general anaesthetic for GLP-1 users.
Subscribe: http://ab.co/1svxLVE
Read more here: https://www.abc.net.au/news/2026-10-07/peptides-ozempic-surgery-warning/107233212
Note: In most cases, our captions are auto-generated.